Polyplex Nanomicelle‐Mediated Pgc‐1α4 mRNA Delivery Via Hydrodynamic Limb Vein Injection Enhances Damage Resistance in Duchenne Muscular Dystrophy Mice

Abstract Duchenne muscular dystrophy (DMD) is caused by mutations in the DMD gene, leading to the absence of dystrophin and progressive muscle degeneration. Current therapeutic strategies, such as exon‐skipping and gene therapy, face limitations including truncated dystrophin production and safety c...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xuan Du, Hideyuki Nakanishi, Takashi Yamada, Yooksil Sin, Katsura Minegishi, Norio Motohashi, Yoshitsugu Aoki, Keiji Itaka
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2025-04-01
coleção:	Advanced Science
Assuntos:	duchenne muscular dystrophy (DMD) lipid nanoparticle (LNP) mRNA therapeutics peroxisome proliferator‐activated receptor gamma coactivator (PGC‐1α) polyplex nanomicelle
Acesso em linha:	https://doi.org/10.1002/advs.202409065
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!